Based on the available researches, it emerges that subnuclear localization of NAT10-specifically whether it resides in the nucleolus versus the nucleoplasm-determines cellular progression outcomes upon the presence or absence of DNA damage in breast cancer. The gene discussed is NAT10; the disease is breast carcinoma.